In Waves & War: Marcus & Amber Capone On Psychedelic Treatment For Veteran PTSD, Rebuilding Life After War & The Mission To Heal A Generation

What It Covers

Marcus and Amber Capone, founders of the veteran nonprofit VETS, recount Marcus's 13-year Navy SEAL career, subsequent PTSD and TBI diagnosis, failed conventional treatments, and eventual recovery through Ibogaine therapy in Mexico. Host Rich Roll shares his own 19-day-post-ceremony perspective, while a Stanford study documents 86–93% improvement in PTSD, depression, and anxiety among veteran participants.

Key Questions Answered

• •Ibogaine medical protocol: Before treatment, patients undergo blood work, urinalysis, and EKGs due to Ibogaine's cardiac risk profile. All pharmaceuticals and antidepressants must be tapered under psychiatric supervision — a process that can take weeks for those on medications for 10–20 years. The drug itself, a single alkaloid extracted from the West African Iboga plant, enters the bloodstream within 45–60 minutes of oral ingestion and produces effects lasting 8–12+ hours.
• •Stanford clinical outcomes: A Stanford Brain Stimulation Lab study led by Dr. Nolan Williams measured PTSD, depression, and anxiety effect sizes improving 86–93% in special operations veterans following Ibogaine treatment. Brain imaging revealed neurological restoration — increased blood flow to previously dark or inactive regions — that researchers had not previously observed from any pharmaceutical intervention. Cognitive functioning scores also improved measurably, validating what Amber Capone had observed anecdotally years earlier.
• •Childhood trauma as performance fuel: Amber Capone observes across 1,300+ veterans treated through VETS that childhood trauma is a near-universal common thread. That unresolved trauma functionally fuels elite performance — creating the drive, compartmentalization, and pain tolerance required for special operations selection — but eventually becomes the primary threat to the individual's survival. The same mechanism that enables peak performance in high-stakes environments later manifests as depression, addiction, and suicidality in civilian life.
• •The "identify and eliminate" suicide mechanism: A suicide interventionist explained to Amber that soldiers trained to identify and neutralize threats become acutely dangerous when they identify themselves as the threat. Marcus describes methodically calculating that his family would experience short-term grief followed by long-term relief without him present. Recognizing this cognitive pattern — rather than treating it as a character flaw — reframes veteran suicide risk as a trained behavioral response requiring neurological, not just psychological, intervention.
• •Integration as the active healing phase: Both Marcus and Amber emphasize that Ibogaine opens a neuroplasticity window, but the behavioral work during integration determines long-term outcomes. Marcus's recovery protocol post-treatment includes daily breathwork, meditation, sensory deprivation, community engagement, and faith practice. He has returned for six sessions over eight years, with each successive experience becoming less difficult and more positive — the most recent described as six hours of sustained bliss versus the first session's prolonged darkness and physical purging.
• •Antidepressant paradox in veteran care: Amber identifies a systemic contradiction: the primary pharmaceutical intervention for veteran suicide risk — antidepressants — carries an FDA-required label warning of increased suicidality risk. Marcus spent years on these medications without improvement, becoming progressively more hopeless with each failed treatment. This pattern of pharmaceutical-first intervention, combined with the military's cultural stigma around help-seeking (fear of losing security clearance or operational status), creates a compounding barrier to effective care.
• •Trauma universality across civilian and military populations: Marcus explicitly rejects the hierarchy of trauma, stating that a civilian who experienced a severe car accident carries neurologically identical stress responses to combat veterans. The brain cannot distinguish between battlefield and civilian traumatic events. VETS now treats a significant number of non-veterans — including investment bankers, teachers, and nurses — presenting with the same depression, anxiety, and addiction patterns. This positions Ibogaine therapy as a broadly applicable mental health intervention, not a niche veteran treatment.